NAPP PHARMACEUTICALS LIMITED — China drug registrations and re-registration deadlines
34 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-05-21.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20220086 | Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets 羟考酮纳洛酮缓释片 | 2027-11-21 | 2027-05-21 |
| 国药准字HJ20220087 | Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets 羟考酮纳洛酮缓释片 | 2027-11-21 | 2027-05-21 |
| 国药准字HJ20220088 | Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets 羟考酮纳洛酮缓释片 | 2027-11-21 | 2027-05-21 |
| 国药准字HJ20220089 | Oxycodone Hydrochloride and Naloxone Hydrochloride Sustained-release Tablets 羟考酮纳洛酮缓释片 | 2027-11-21 | 2027-05-21 |
| 国药准字HJ20180033 | Oxycodone Hydrochloride Capsules 盐酸羟考酮胶囊 | 2028-07-03 | 2028-01-03 |
| 国药准字HJ20180034 | Oxycodone Hydrochloride Capsules 盐酸羟考酮胶囊 | 2028-07-03 | 2028-01-03 |
| 国药准字HJ20180035 | Oxycodone Hydrochloride Capsules 盐酸羟考酮胶囊 | 2028-07-03 | 2028-01-03 |
| 国药准字HJ20181253 | Oxycodone Hydrochloride Capsules 盐酸羟考酮胶囊 | 2028-07-03 | 2028-01-03 |
| 国药准字HJ20181254 | Oxycodone Hydrochloride Capsules 盐酸羟考酮胶囊 | 2028-07-03 | 2028-01-03 |
| 国药准字HJ20181255 | Oxycodone Hydrochloride Capsules 盐酸羟考酮胶囊 | 2028-07-03 | 2028-01-03 |
| 国药准字HJ20230106 | Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation 氟替卡松福莫特罗吸入气雾剂 | 2028-09-11 | 2028-03-11 |
| 国药准字HJ20230107 | Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation 氟替卡松福莫特罗吸入气雾剂 | 2028-09-11 | 2028-03-11 |
| 国药准字HJ20230108 | Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation 氟替卡松福莫特罗吸入气雾剂 | 2028-09-11 | 2028-03-11 |
| 国药准字HJ20140312 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140313 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140314 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140315 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140316 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140317 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140318 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140319 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140320 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140321 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140322 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140323 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140324 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20140325 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20170052 | OXYCONTIN 盐酸羟考酮缓释片 | 2029-02-05 | 2028-08-05 |
| 国药准字HJ20130900 | Morphine Sulphate Sustained-release Tablets 硫酸吗啡缓释片 | 2029-06-13 | 2028-12-13 |
| 国药准字HJ20130901 | Morphine Sulphate Sustained-release Tablets 硫酸吗啡缓释片 | 2029-06-13 | 2028-12-13 |
| 国药准字HJ20130903 | Morphine Sulphate Sustained-release Tablets 硫酸吗啡缓释片 | 2029-06-13 | 2028-12-13 |
| 国药准字HJ20130904 | Morphine Sulphate Sustained-release Tablets 硫酸吗啡缓释片 | 2029-06-13 | 2028-12-13 |
| 国药准字HJ20130899 | Morphine Sulfate Sustained-release Tablets 硫酸吗啡缓释片 | 2031-02-24 | 2030-08-24 |
| 国药准字HJ20130902 | Morphine Sulfate Sustained-release Tablets 硫酸吗啡缓释片 | 2031-02-24 | 2030-08-24 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.